In December 2017, the Company granted 1,000,000 share purchase warrants to a consultant of the Company for professional services. The warrants are exercisable into common shares at $0.10 per share for a period of five years. The fair value of the share purchase warrants was $101,310 calculated using the Black-Scholes Option Pricing Model assuming volatility of 154%, risk-free rate of 1.0%, expected life of 5 years, and no expected dividends.

In September 2018, the Company granted 2,000,000 share purchase warrants to a loan holder of the Company in exchange for an extension for the maturity of its promissory notes dated February 16, 2017 and July 25, 2018. The maturity date has been extended until June 30, 2019. The warrants are exercisable into common shares at $0.10 per share for a period of five years. The fair value of the share purchase warrants was $267,560 calculated using the Black-Scholes Option Pricing Model assuming volatility of 227%, risk-free rate of 2.7%, expected life of 5 years, and no expected dividends.

In September 2018, the Company granted 3,850,000 share purchase warrants to a loan holder of the Company. The warrants are exercisable into common shares at between $0.01 and $0.15 per share for a period of five years. The fair value of the share purchase warrants was $518,137 calculated using the Black-Scholes Option Pricing Model assuming volatility of 227%, risk-free rate of 2.7%, expected life of 5 years, and no expected dividends.

	Number of warrants	Weighted average exercise price $
Balance, September 30, 2017	2,742,000	0.05
Issued	6,850,000	0.10
Exercised	(666,666)	0.001

Balance, September 30, 2018	8,925,334	0.10

Additional information regarding share purchase warrants as of September 30, 2018, is as follows:

	Outstanding and exercisable
Range of Exercise Prices $	Number of Warrants	Weighted Average Remaining Contractual Life (years)
0.001	1,333,334	0.9
0.01	3,600,000	4.9
0.10	1,000,000	0.8
0.15	750,000	1.8
0.50	242,000	0.1
0.10	2,000,000	1.9

	8,925,334	4.4